Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. - Wikidata - awgldk - TriplyDB

Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.

Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.

http://www.wikidata.org/entity/Q34128708

about

Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment.The emerging roles of liver X receptors and their ligands in cancer.Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma.Liver X receptors as potential targets for cancer therapeutics.

P2860

Q36545158-B824889F-7E77-4AD1-BEC3-F6448F779A15 Q37376541-5B410F8A-CB6C-4A45-BB34-CE23502CBC68 Q37572922-218C589D-7EFE-4EE9-AD94-B19B8241326A Q38703765-73799603-DB30-4FF2-8465-170FAF5BE5A9 Q46243388-B4649981-EF59-4E96-B7F8-44F643A7C5CD Q47155172-262C6F0A-0B4A-45EF-BADE-80EB7B32F746

P2860

Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.

http://www.wikidata.org/entity/Q34128708

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@ast

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@en

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@nl

type

label

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@ast

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@en

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@nl

prefLabel

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@ast

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@en

Antiproliferative effects and ...... c ductal adenocarcinoma cells.

@nl

P1433

Q34128708-5020ABE0-122F-4466-B04A-77376F3982EB

P1476

Q34128708-04E761D4-5155-45B7-A954-9E6F062AB5E2

P2093

Q34128708-017EBE5D-6D9A-4FAD-B8FA-03429186EF58

Q34128708-0569A401-3830-4E70-A69F-D2F5B444AE1E

Q34128708-21C71029-C0C3-42F6-ADB2-0279BC7AF0CE

Q34128708-2973EB0C-38B3-4D83-AE5A-BFD948EE28E9

Q34128708-2C4BFFEF-A518-4F47-A6A2-4602F8BD3431

Q34128708-40D3ABAF-57B8-4F26-8D13-C585F7AB1465

Q34128708-5F17770D-D120-47FB-8128-DF95C48242F0

Q34128708-63EAA287-423E-4AD0-85C7-888BE037A044

Q34128708-67B3260B-F7BD-4F51-AB88-9FACA72756A2

Q34128708-8113BA8D-BC62-4585-A17C-2E6EC1E889A1

P2860

Q34128708-0160B7A9-3B79-48E4-B1CB-B0A52E98F059

Q34128708-0604388B-252E-4043-A562-0F439757878C

Q34128708-08F708F4-F9DA-4AC2-A1CB-E8401EB4514C

Q34128708-0BE1CB79-37BE-43BF-9A2C-AF86CDFC1E06

Q34128708-10140C4E-2C67-48EE-AF17-AA05EFB9FCDE

Q34128708-21B7B12E-A1BA-401E-8E71-F062F540057D

Q34128708-33F8260E-DD10-4431-B84C-6540452DB15B

Q34128708-3F13B622-466D-4D92-A867-B4BFA5331FF2

Q34128708-4E33D2F3-0C1C-4905-AB40-725BAB9929D4

Q34128708-534A5CBB-469F-4BE1-9875-59CBCB24A148

P304

Q34128708-6B784BFF-2627-486F-911A-4D67113DAB26

P31

Q34128708-219BDA49-7889-4793-B1E5-C8789AA629F5

P356

Q34128708-1F51C58C-2EAC-4E72-8C1B-B33169DCEBAC

P407

Q34128708-B8EA5AA2-F438-4B9A-B4CC-28DE980F63F5

P433

Q34128708-03A621F8-9EAB-4700-9670-3538DEEB97B6

P478

Q34128708-7F3FC2F3-B253-4405-A23C-97CBF9AC79C0

P50

Q34128708-5DDA928D-0CFC-4999-B518-9B44E31CE83E

Q34128708-6129E60A-FE95-4A14-B8F6-0DCBF7DFD668

Q34128708-CD7A20BC-39E8-4BEC-B4F0-DDE402CDDA4F

Q34128708-F9AA2A97-B04F-4CAD-9050-7E495EB25585

P577

Q34128708-85C3F3C8-192A-4C1D-BE7D-5CE3A244C523

P5875

Q34128708-E0D0504E-F009-4ED3-956A-AADD656B0452

P698

Q34128708-C3F0BEF8-DC41-4555-A11A-B2933B3D0D37

P921

Q34128708-28EC67C9-BA0F-4813-B9DC-15179EECBEE1

P932

Q34128708-F3C7F622-C9BD-47F2-A6C1-095971F4489E

P356

JOURNAL.PONE.0106289

P1433

P1476

Antiproliferative effects and ...... ic ductal adenocarcinoma cells

@en

P2093

Amy L McElhany

http://www.w3.org/2001/XMLSchema#string

Chin-Yo Lin

http://www.w3.org/2001/XMLSchema#string

Fei Su

http://www.w3.org/2001/XMLSchema#string

Husna Karaboga

http://www.w3.org/2001/XMLSchema#string

Jan-Åke Gustafsson

http://www.w3.org/2001/XMLSchema#string

Jean Z Lin

http://www.w3.org/2001/XMLSchema#string

Jine Zheng

http://www.w3.org/2001/XMLSchema#string

Ka Liu

http://www.w3.org/2001/XMLSchema#string

Knut R Steffensen

http://www.w3.org/2001/XMLSchema#string

Mehdi A Issazadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Counting colonies of clonogenic assays by using densitometric software

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

Nuclear hormone receptors and gene expression

Molecular determinants for the tissue specificity of SERMs

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

Pancreatic exocrine insufficiency in LXRbeta-/- mice is associated with a reduction in aquaporin-1 expression

The druggable genome

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

P304

e106289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0106289

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Lakshmi Reddy Bollu

Lise-Lotte Vedin

P577

2014-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265394391

http://www.w3.org/2001/XMLSchema#string

P698

25184494

http://www.w3.org/2001/XMLSchema#string

P921

P932

4153644

http://www.w3.org/2001/XMLSchema#string